Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma

被引：18
作者：
Schwarz, Lilian [1 ]
Katz, Matthew Harold G. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2015年 / 29卷 / 04期
关键词：
Borderline resectable; Pancreatic cancer; Pancreatoduodenectomy; Neoadjuvant therapy; Chemotherapy; Chemoradiation; GEMCITABINE-BASED CHEMORADIATION; IN-HOSPITAL MORTALITY; PREOPERATIVE GEMCITABINE; CONCURRENT CHEMORADIATION; ENDOSCOPIC ULTRASOUND; NEOADJUVANT THERAPY; COMPUTED-TOMOGRAPHY; CONSENSUS STATEMENT; STAGING LAPAROSCOPY; EARLY RECURRENCE;
D O I：
10.1016/j.hoc.2015.04.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Borderline resectable pancreatic cancer represents a subcategory of advanced cancer that is typically defined by limited involvement of the major mesenteric vasculature. Such involvement is associated with a high likelihood of microscopically incomplete resection if surgery is used as the primary therapeutic modality. Increasing data support the role of neo-adjuvant therapy as part of multimodality management but there is no uniformly accepted standard of care. This review discusses, based on recent literature and the experience of the Pancreatic Tumor Study Group at The University of Texas MD Anderson Cancer Center, the classification, definition, diagnosis, and management of borderline resectable pancreatic cancer.
引用
收藏
页码：727 / +
页数：15
相关论文
共 67 条
  • [1] Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
    Abrams, Ross A.
    Lowy, Andrew M.
    O'Reilly, Eileen M.
    Wolff, Robert A.
    Picozzi, Vincent J.
    Pisters, Peter W. T.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) : 1751 - 1756
  • [2] Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
    Al-Hawary, Mahmoud M.
    Francis, Isaac R.
    Chari, Suresh T.
    Fishman, Elliot K.
    Hough, David M.
    Lu, David S.
    Macari, Michael
    Megibow, Alec J.
    Miller, Frank H.
    Mortele, Koenraad J.
    Merchant, Nipun B.
    Minter, Rebecca M.
    Tamm, Eric P.
    Sahani, Dushyant V.
    Simeone, Diane M.
    [J]. GASTROENTEROLOGY, 2014, 146 (01) : 291 - +
  • [3] Is there still a role for laparoscopy combined with laparoscopic ultrasonography in the staging of pancreatic cancer?
    Barabino, Matteo
    Santambrogio, Roberto
    Ceretti, Andrea Pisani
    Scalzone, Rocco
    Montorsi, Marco
    Opocher, Enrico
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (01): : 160 - 165
  • [4] Trends in the treatment and outcome of pancreatic cancer in the United States
    Baxter, Nancy N.
    Whitson, Bryan A.
    Tuttle, Todd M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) : 1320 - 1326
  • [5] Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer
    Bilimoria, Karl Y.
    Talamonti, Mark S.
    Sener, Stephen F.
    Bilimoria, Malcolm M.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Bentrem, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (04) : 510 - 519
  • [6] National failure to operate on early stage pancreatic cancer
    Bilimoria, Karl Y.
    Bentrem, David J.
    Ko, Clifford Y.
    Stewart, Andrew K.
    Winchester, David P.
    Talamonti, Mark S.
    [J]. ANNALS OF SURGERY, 2007, 246 (02) : 173 - 180
  • [7] Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma -: A meta-analysis
    Bipat, S
    Phoa, SSKS
    van Delden, OM
    Bossuyt, PMM
    Gouma, DJ
    Laméris, JS
    Stoker, J
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2005, 29 (04) : 438 - 445
  • [8] Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1016/S0039-6060(99)70234-5
  • [9] Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
    Bockhorn, Maximilian
    Uzunoglu, Faik G.
    Adham, Mustapha
    Imrie, Clem
    Milicevic, Miroslav
    Sandberg, Aken A.
    Asbun, Horacio J.
    Bassi, Claudio
    Buechler, Markus
    Charnley, Richard M.
    Conlon, Kevin
    Cruz, Laureano Fernandez
    Dervenis, Christos
    Fingerhutt, Abe
    Friess, Helmut
    Gouma, Dirk J.
    Hartwig, Werner
    Lillemoe, Keith D.
    Montorsi, Marco
    Neoptolemos, John P.
    Shrikhande, Shailesh V.
    Takaori, Kyoichi
    Traverso, William
    Vashist, Yogesh K.
    Vollmer, Charles
    Yeo, Charles J.
    Izbicki, Jakob R.
    [J]. SURGERY, 2014, 155 (06) : 977 - 988
  • [10] Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
    Callery, Mark P.
    Chang, Kenneth J.
    Fishman, Elliot K.
    Talamonti, Mark S.
    Traverso, L. William
    Linehan, David C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) : 1727 - 1733
1234567